| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |